BioMarin Pharmaceutical Inc. (BIT:1BMRN)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	9,994	9,788	10,768	15,616	16,552	13,954
Market Cap Growth	-15.42%	-9.10%	-31.05%	-5.66%	18.63%	1.96%
Enterprise Value	9,205	8,961	10,302	15,627	16,373	14,010
PE Ratio	33.63	33.02	29.74	110.83	137.99	-252.43
Forward PE	10.87	12.37	17.86	38.98	39.00	85.79
PEG Ratio	-	0.65	0.72	1.07	0.86	2.66
PS Ratio	3.64	3.54	4.39	7.52	9.20	8.80
PB Ratio	1.93	1.87	2.22	3.67	4.19	3.81
P/TBV Ratio	1.78	1.93	2.29	3.73	4.25	3.79
P/FCF Ratio	16.19	15.72	25.72	290.64	350.82	77.76
P/OCF Ratio	14.17	13.77	21.89	114.18	109.58	53.36
EV/Sales Ratio	3.32	3.24	4.20	7.52	9.10	8.84
EV/EBITDA Ratio	14.58	21.34	20.66	62.72	72.51	634.83
EV/EBIT Ratio	16.45	25.48	24.77	97.96	118.45	-198.13
EV/FCF Ratio	14.91	14.39	24.61	290.85	347.02	78.07
Debt / Equity Ratio	0.10	0.10	0.11	0.22	0.24	0.25
Debt / EBITDA Ratio	1.22	1.22	1.02	3.75	4.12	41.99
Debt / FCF Ratio	0.82	0.82	1.22	17.37	19.71	5.16
Net Debt / Equity Ratio	-0.16	-0.16	-0.10	0.00	-0.04	0.02
Net Debt / EBITDA Ratio	-1.97	-1.97	-0.93	0.05	-0.79	2.54
Net Debt / FCF Ratio	-1.33	-1.33	-1.11	0.21	-3.79	0.31
Asset Turnover	0.44	0.44	0.41	0.37	0.34	0.31
Inventory Turnover	0.57	0.57	0.50	0.53	0.60	0.64
Quick Ratio	3.25	3.25	2.96	1.45	2.98	2.54
Current Ratio	5.21	5.21	5.33	2.51	4.67	4.16
Return on Equity (ROE)	5.94%	5.94%	8.05%	3.51%	3.19%	-1.53%
Return on Assets (ROA)	4.06%	4.06%	5.52%	2.50%	2.46%	-1.18%
Return on Invested Capital (ROIC)	5.63%	5.63%	7.39%	3.44%	3.38%	-1.59%
Return on Capital Employed (ROCE)	6.20%	6.20%	8.04%	3.24%	2.86%	-1.52%
Earnings Yield	2.97%	3.03%	3.36%	0.90%	0.72%	-0.40%
FCF Yield	6.18%	6.36%	3.89%	0.34%	0.29%	1.29%
Buyback Yield / Dilution	0.36%	0.36%	0.23%	0.04%	-0.08%	-0.02%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.